Quick Answer
Revium Rx. reported Cash and Equivalents of $1.68 million for fiscal year 2025.
Revium Rx. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.68M | -48.7% |
| 2024 | $3.27M | — |
- Revium Rx. showed a decrease of -48.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2024–2025 period, Revium Rx.’s cash and equivalents has declined by 48.7% (from $3.27 million to $1.68 million).
- The most recent figure is from Revium Rx.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: